论文部分内容阅读
目的研究分析阿托伐他汀用于缺血性脑血管疾病患者二级预防中的治疗效果以及预防价值。方法 102例缺血性脑血管疾病患者,随机分为干预分析组和对照分析组,各51例。对照分析组采用阿司匹林治疗,干预分析组采用阿司匹林+阿托伐他汀治疗,对比分析两组治疗的疗效及远期效果。结果干预分析组患者的优良率为96.08%显著高于对照分析组的76.47%,差异具有统计学意义(P<0.05)。对照分析组复发率为11.76%明显高于干预分析组的1.96%(P<0.05)。结论阿托伐他汀用于缺血性脑血管疾病的治疗效果和预防价值较高,值得推广使用。
Objective To study the therapeutic effect and the preventive value of atorvastatin in the secondary prevention of patients with ischemic cerebrovascular disease. Methods A total of 102 patients with ischemic cerebrovascular disease were randomly divided into intervention analysis group and control group, with 51 cases in each group. The control group was treated with aspirin, and the intervention group was treated with aspirin + atorvastatin. The curative effect and long-term effect were compared between the two groups. Results The excellent and good rate of intervention group was 96.08%, which was significantly higher than that of control group (76.47%), the difference was statistically significant (P <0.05). The recurrence rate was 11.76% in the control group and 1.96% in the intervention group (P <0.05). Conclusions Atorvastatin is of high value in the treatment and prevention of ischemic cerebrovascular diseases and should be widely used.